Columbia Sportswear Co
Change company Symbol lookup
Select an option...
COLM Columbia Sportswear Co
HEAR Turtle Beach Corp
GWPH GW Pharmaceuticals PLC
GTBIF Green Thumb Industries Inc
GOOG Alphabet Inc
GILD Gilead Sciences Inc
GBLX GB Sciences Inc
FANG Diamondback Energy Inc
EOG EOG Resources Inc
DVN Devon Energy Corp
Go

Consumer Discretionary : Textiles, Apparel & Luxury Goods | Mid Cap Blend
Company profile

Columbia Sportswear Company is an apparel and footwear company. The Company designs, sources, markets and distributes outdoor lifestyle apparel, footwear, accessories and equipment under the Columbia, Mountain Hardwear, Sorel, prAna and other brands. Its geographic segments are the United States, Latin America and Asia Pacific (LAAP), Europe, Middle East and Africa (EMEA), and Canada. The Company develops and manages its merchandise in categories, including apparel, accessories and equipment, and footwear. It distributes its products through a mix of wholesale distribution channels, its own direct-to-consumer channels (retail stores and e-commerce), independent distributors and licensees. As of December 31, 2016, its products were sold in approximately 90 countries. In 59 of those countries, it sells to independent distributors to whom it has granted distribution rights. Contract manufacturers located outside the United States manufacture all of its products.

Closing Price
$66.18
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
472,664
0

T2 Biosystems Reports Granting of Inducement Award

4:15 pm ET January 17, 2020 (Globe Newswire) Print

T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it issued an inducement award to John Sperzel, the Company's recently appointed Chief Executive Officer and President, in accordance with the terms of Mr. Sperzel's employment agreement.

The award was made on January 8, 2020 under T2 Biosystems' Inducement Award Plan (the "Inducement Plan"), which was adopted March 1, 2018 and amended and restated on January 8, 2020 and provides for the granting of equity awards to new employees of T2 Biosystems. The inducement award consists of an option to purchase 3,000,000 shares of T2 Biosystems common stock and has a ten-year term. The exercise price of the option was $1.15, which was the per-share closing price of T2 Biosystems common stock on the Nasdaq Capital Market on January 8, 2020. The option vests in equal monthly installments over the four-year period following the grant date. The award was approved by the independent compensation committee of T2 Biosystems' board of directors and was granted as an inducement material to the new employee entering into employment with T2 Biosystems in accordance with Nasdaq Marketplace Rule 5635(c)(4).

About T2 Biosystems:

T2 Biosystems, a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems' products include the T2Dx Instrument, T2Candida Panel, T2Bacteria Panel, and the T2Resistance Panel(TM) and are powered by the proprietary T2 Magnetic Resonance (T2MR) technology. T2 Biosystems has an active pipeline of future products, including products for the detection of additional species and antibiotic resistance markers of sepsis pathogens, and tests for Lyme disease.

Media Contact:

Gina Kent, Vault Communications

gkent@vaultcommunications.com

610-455-2763

Investor Contact:

Zack Kubow, W2O Group

zkubow@w2ogroup.com

415-658-6436

https://ml.globenewswire.com/media/21ce43b1-81a5-42af-8c47-c2df2e179d21/small/t2biosystems-logo-jpg.jpg

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.